Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 59, Issue 20, Pages 9457-9472Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b01127
Keywords
-
Categories
Ask authors/readers for more resources
A novel series of second generation DPP1 inhibitors free from aorta binding liabilities found for earlier compound series was discovered. This work culminated in the identification of compound 30 (AZD7986) as a highly potent, reversible, and selective clinical candidate for COPD, with predicted human PK properties suitable for once daily human dosing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available